Comparison of Survival in Patients with Isolated Peritoneal Carcinomatosis from Colorectal Cancer Treated with Cytoreduction and Melphalan or Mitomycin-C as Hyperthermic Intraperitoneal Chemotherapy Agent

BACKGROUND: The role of hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis (PC) from colorectal cancer (CRC) is debated. Melphalan as a perfusion agent has also demonstrated survival benefit in other recurrent and chemoresistant malignancies. Thus, we hypothesize that me...

Descripción completa

Detalles Bibliográficos
Autores principales: Sipok, Arkadii, Sardi, Armando, Nieroda, Carol, King, Mary Caitlin, Sittig, Michelle, Gushchin, Vadim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311272/
https://www.ncbi.nlm.nih.gov/pubmed/30643644
http://dx.doi.org/10.1155/2018/1920276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311272/
https://www.ncbi.nlm.nih.gov/pubmed/30643644
http://dx.doi.org/10.1155/2018/1920276

Ejemplares similares